157 related articles for article (PubMed ID: 23479396)
21. Radioresistant tumor cell lines derived from head and neck radiation failures.
Weichselbaum RR; Beckett MA; Vijayakumar S; Ahmed-Swan S; Dritschilo A; Schwartz JL; Moran WJ; Goldman ME; Tybor AG; Vokes EE
Head Neck; 1989; 11(4):343-8. PubMed ID: 2753702
[TBL] [Abstract][Full Text] [Related]
22. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
23. Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression.
Fenwick JD
Phys Med Biol; 1998 Aug; 43(8):2159-78. PubMed ID: 9725596
[TBL] [Abstract][Full Text] [Related]
24. External Validation of Early Regression Index (ERI
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Broggi S; Romano A; Mori M; Barbaro B; Azario L; Gambacorta MA; De Spirito M; Bassetti MF; Yang Y; Fiorino C; Valentini V
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1347-1356. PubMed ID: 32758641
[TBL] [Abstract][Full Text] [Related]
25. [Determination of potential doubling time using in vitro continuous labeling method with bromodeoxyuridine: estimation in head and neck squamous cell carcinoma].
Mariya Y; Aoki M; Tarusawa N; Takekawa S; Kaimori M; Abe Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):976-8. PubMed ID: 8371947
[TBL] [Abstract][Full Text] [Related]
26. Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
Alsner J; Høyer M; Sørensen SB; Overgaard J
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):519-25. PubMed ID: 11173149
[TBL] [Abstract][Full Text] [Related]
27. Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy.
Weichselbaum R; Dahlberg W; Little JB; Ervin TJ; Miller D; Hellman S; Rheinwald JG
Br J Cancer; 1984 May; 49(5):595-601. PubMed ID: 6722007
[TBL] [Abstract][Full Text] [Related]
28. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.
Butler WM; Stewart RR; Merrick GS
Med Phys; 2009 Mar; 36(3):776-87. PubMed ID: 19378738
[TBL] [Abstract][Full Text] [Related]
29. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
Begg AC; Hofland I; Kummermehr J
Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
[TBL] [Abstract][Full Text] [Related]
30. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability.
Brock WA; Baker FL; Peters LJ
Int J Radiat Biol; 1989 Nov; 56(5):751-60. PubMed ID: 2573673
[TBL] [Abstract][Full Text] [Related]
31. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
King CR; DiPetrillo TA; Wazer DE
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
[TBL] [Abstract][Full Text] [Related]
32. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
[TBL] [Abstract][Full Text] [Related]
33. In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
Stausbøl-Grøn B; Bentzen SM; Jørgensen KE; Nielsen OS; Bundgaard T; Overgaard J
Br J Cancer; 1999 Mar; 79(7-8):1074-84. PubMed ID: 10098739
[TBL] [Abstract][Full Text] [Related]
34. Clinical radiobiology of head and neck cancer: the hypothesis of stem cell activation.
Pedicini P; Caivano R; Fiorentino A; Strigari L
Clin Transl Oncol; 2015 Jun; 17(6):469-76. PubMed ID: 25487602
[TBL] [Abstract][Full Text] [Related]
35. Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.
Zips D; Eicheler W; Brüchner K; Jackisch T; Geyer P; Petersen C; van der Kogel AJ; Baumann M
Int J Radiat Biol; 2001 Dec; 77(12):1185-93. PubMed ID: 11747543
[TBL] [Abstract][Full Text] [Related]
36. The effects of delays in radiotherapy treatment on tumour control.
Wyatt RM; Beddoe AH; Dale RG
Phys Med Biol; 2003 Jan; 48(2):139-55. PubMed ID: 12587901
[TBL] [Abstract][Full Text] [Related]
37. Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy.
Avanzo M; Stancanello J; Franchin G; Sartor G; Jena R; Drigo A; Dassie A; Gigante M; Capra E
Med Phys; 2010 Apr; 37(4):1533-44. PubMed ID: 20443474
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans.
Wang H; Cooper BT; Schiff P; Sanfilippo NJ; Wu SP; Hu KS; Das IJ; Xue J
Br J Radiol; 2019 Feb; 92(1094):20180471. PubMed ID: 30209959
[TBL] [Abstract][Full Text] [Related]
39. Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer.
Deb P; Fielding A
Australas Phys Eng Sci Med; 2009 Jun; 32(2):51-61. PubMed ID: 19623855
[TBL] [Abstract][Full Text] [Related]
40. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
